ABATACEPT RETENTION RATES AND PROGNOSTIC FACTORS OF RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: 2-YEAR RESULTS FROM THE REAL-WORLD ACTION STUDY

被引：1
|
作者：
Alten, R. [1 ]
Lorenz, H-M. [2 ]
Mariette, X. [3 ]
Nuesslein, H. [4 ]
Galeazzi, M. [5 ]
Navarro, F. [6 ]
Chartier, M. [7 ]
Elbez, Y. [8 ]
Rauch, C. [9 ]
Le Bars, M. [7 ]
机构：
[1] Schlosspk Klin Univ Med, Berlin, Germany
[2] Univ Hosp, Heidelberg, Germany
[3] Univ Paris Sud, Paris, France
[4] Univ Erlangen Nurnberg, Nurnberg, Germany
[5] Univ Siena, Siena, Italy
[6] Hosp Univ Virgen Macarena, Seville, Spain
[7] Bristol Myers Squibb, Rueil Malmaison, France
[8] Excelya, Boulogne, France
[9] Bristol Myers Squibb, Munich, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0245
引用
收藏
页码：577 / 578
页数：2
相关论文
共 50 条
  • [41] Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study
    Pascal Hilliquin
    Thomas Barnetche
    Athan Baillet
    René-Marc Flipo
    Eric Lespessailles
    Christian Roux
    Patrice Fardellone
    Anika Gilbert-Marceau
    Isabelle Idier
    Arnaud Constantin
    Emilie Shipley
    Guy Baudens
    Alain Saraux
    [J]. Rheumatology and Therapy, 2021, 8 : 95 - 108
  • [42] Predictive factors for retention of golimumab over a median 4-year duration in Japanese patients with rheumatoid arthritis in a real-world setting: A retrospective study and literature review
    Mutoh, Tomoyuki
    Nagai, Taichi
    Shirai, Tsuyoshi
    Okazaki, Soshi
    Sato, Hiroko
    Fujii, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (03) : 335 - 343
  • [43] Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
    Dougados, Maxime
    Lucas, Julien
    Desfleurs, Emilie
    Claudepierre, Pascal
    Goupille, Philippe
    Ruyssen-Witrand, Adeline
    Saraux, Alain
    Tournadre, Anne
    Wendling, Daniel
    Lukas, Cedric
    [J]. RMD OPEN, 2023, 9 (01):
  • [44] Predictors of Golimumab Retention among Patients with Rheumatoid Arthritis on Stable Treatment in Canadian Real-world Setting
    Keystone, Edward
    Haaland, Derek
    Sheriff, Maqbool
    Joshi, Raman
    Jovaisas, Algis
    Haraoui, Boules
    Arendse, Regan
    Tsoukas, Alexender
    Starr, Michael
    Bessette, Louis
    Boulos, Pauline
    Thorne, Carter
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    Osborne, Brendan
    Maslova, Karina
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 921 - 921
  • [45] Comparing Real-world Retention Rates in a Matched Cohort of Rheumatoid Arthritis Patients Who Either Remained on the Etanercept Originator or Switched to a Biosimilar
    Baganz, Lisa
    Strangfeld, Anja
    Herzer, Peter
    Krause, Andreas
    Tony, Hans-Peter
    Zink, Angela
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] A COMPARATIVE EFFECTIVENESS STUDY OF ABATACEPT AND TNFI AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USING REAL-WORLD DATA
    Alemao, Evo
    Connolly, Sean
    Elbez, Yedid
    Rao, Aarti
    Saini, Yogesh
    Iannaccone, Christine
    Weinblatt, Michael E.
    Shadick, Nancy
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1646 - 1647
  • [47] COMPARING REAL-WORLD RETENTION RATES IN A MATCHED COHORT OF RHEUMATOID ARTHRITIS PATIENTS WHO EITHER REMAINED ON THE ETANERCEPT ORIGINATOR OR SWITCHED TO A BIOSIMILAR
    Baganz, Lisa
    Strangfeld, Anja
    Herzer, Peter
    Krause, Andreas
    Tony, Hans-Peter
    Zink, Angela
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1136 - 1136
  • [48] EFFICACY AND SAFETY OF ABATACEPT IN CHINESE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: REAL-WORLD DATA
    Qing, Y. F.
    Huang, Q.
    Zhao, Z. Y.
    Zhang, Q. B.
    Li, L. Q.
    Wen, Z.
    You, Z. X.
    Tang, H.
    Xu, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1291 - 1292
  • [49] Does Body Mass Index Impact Long-Term Retention with Abatacept in Patients with RA Who Have Received at Least One Prior Biologic Agent? 2-Year Results from a Real-World, International, Prospective Study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, Gerd
    Peter, H-H
    Peichl, P.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1088 - S1089
  • [50] DOES BODY MASS INDEX IMPACT LONG-TERM RETENTION WITH ABATACEPT IN PATIENTS WITH RA WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT? 2-YEAR RESULTS FROM A REAL-WORLD, INTERNATIONAL, PROSPECTIVE STUDY
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H.
    Nurmohamed, M.
    Benson, W.
    Burmester, G.
    Peter, H.
    Peichl, P.
    Pavelka, P.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 31 - 32
12345